ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 684459 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 684459; 2) Community: the network communities that were significantly associated with the response to NSC 684459; 3) Molecule: the relationships between components within communities and NSC 684459; 4) MDR: the compounds that were significantly associated with the NSC 684459.

NSC Compound Enrichment Correlation
NSC 661229 Null 0.00888636978630788 0.305845
NSC 661748 [6,6'-Bibenzo[6,7]cyclohepta[1,2,3-cd]benzofuran]-4,4',8,8', 10,10'-hexol, 1,1',6,6',7,7',11b,11'b-octahydro-1,1',7,7'- tetrakis(4-hydroxyphenyl)-, [1.alpha.,6.beta.(1'R*,6'S*,7'R*),7.alpha]- 0.00888636978630788 -0.08152796
NSC 671165 Null 0.00888636978630788 -0.28037818
NSC 674454 (Z)-3-iodo-1,2-diphenyl-2-propen-1-one 0.00888636978630788 -0.24438869
NSC 677959 16.beta.-N-methylpiperazino-5-androstene-3.beta.,17.beta.-diol 0.00888636978630788 -0.20122618
NSC 678989 Uracil, 1-[1,2-bis(ethoxycarbonyl)ethenyl]-, cis- 0.00888636978630788 -0.096319403
NSC 625498 4-Morpholinecarbodithioic acid, antimony complex 0.0102077332082016 -0.21319433
NSC 677240 Null 0.0102077332082016 -0.34590504
NSC 699671 Null 0.0102077332082017 -0.346418
NSC 716522 Null 0.0102077332082017 -0.22330668
Total:86  Current:16    [First] [Prev] [Next] [Last]